Cynosure introduces SculpSure – the first hypothermic laser device for non surgical fat reduction
Many of you are probably aware of Cynosure, one of the most important companies in the industry of Plastic surgery, the manufacturers of SmartLipo, Cellulaze and other reliable aesthetic Devices. The next big thing for Cynosure seems to be something entirely new.. a device that provides hypothermic laser non surgical fat reduction. It’s called SculpSure and its the only FDA-cleared hypothermic non surgical laser fat reduction option.
To introduce the new project Cynosure is hosting an investor event on Tuesday (September 15) in New York City. Cynosure will also host a live webcast of this investor event from 10:00 a.m. to 12:30 p.m. (ET).
Present and hosts of the event will be Cynosure’s President and Chief Financial Officer Timothy Baker, the Chairman and Chief Executive Officer Michael Davin as well as the Executive Vice President of Worldwide Sales Douglas Delaney. Besides Dr. Bruce E. Katz, M.D. of Cosmetic Surgery & Laser Clinic at Mount Sinai Medical Center and of the Juva Skin & Laser Center in New York, will be presenter of the event, describing the clinical experience with the device, while also demonstrating its protocol.
The event will describe the company’s hypothermic laser technology and will highlight Cynosure’s business model, marketing and distribution plans as well as the global market opportunity for SculpSure.
The live webcast will be available at http://www.cynosure.com, on the “Investors” section, while for those not able to watch it live it will be archived for 90 days.